1. Home
  2. > Pharmaceutical
  3. > OTC Market Trends
Dermatologicals Market by Disease, Type, and Route of Administration : Global Opportunity Analysis and Industry Forecast, 2021––2030

Dermatologicals Market by Disease, Type, and Route of Administration : Global Opportunity Analysis and Industry Forecast, 2021––2030

  • January 2022
  • 262 pages
  • ID: 6247253
  • Format: PDF
  • Allied Market Research

Summary

Table of Contents

Dermatologicals Market by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, and Others), Type (Prescription-based Drugs, and Over-the-Counter Drugs), and Route of Administration (Topical Administration, Oral Administration, and Parenteral Administration): Global Opportunity Analysis and Industry Forecast, 2021––2030


The global dermatologicals market was valued at $19,974.3 million in 2020, and is projected to reach $59,309.3 million by 2030, registering a CAGR of 11.5% from 2021 to 2030.

Dermatologicals are a class of medicine used to treat patients suffering from skin disorders. These preparations are used to treat conditions such as psoriasis, acne, and rosacea. Different types of dermatological formulations are available in the market, including topical, parenteral, and oral. The treatment for skin diseases are prescribed depending upon the type and severity of symptoms. For instance, psoriasis requires the use of parenteral dermatological preparations for treatment.

The growth of the global dermatologicals market is majorly driven by alarming increase in prevalence of skin diseases such as acne, atopic dermatitis, psoriasis, and rosacea; rise in government initiatives to spread awareness & promote knowledge about skin disease; surge in number of dermatological drugs manufacturing; surge in expenditure on human healthcare services; and increase in adoption of skin care products. For instance, the American Academy of Dermatology Association aims to develop frontiers of dermatologic care and increase dermatologic services for under-served population. This program further aims to increase consumer understanding about the importance of care delivered by board-certified dermatologists. Moreover, dermatological products are prescribed to patients suffering from COVID-19 and who develop skin diseases such as urticaria, morbilliform rash, and pernio-like acral lesions.

Furthermore, rise in number of teenagers and younger population drive the growth of the market. This is attributed to the fact that the teenager population is highly vulnerable to skin diseases such as acne, due to change in hormonal level, which boosts the demand for various dermatological drug therapies for better health outcomes. This factors is expected to notably contribute toward the growth of the global dermatologicals market.
In addition, the development of the pharmaceutical sector is a major factor that drives the global dermatologicals market. Moreover, increase in number of clinical studies significantly contributes toward the market growth. Clinical studies aim to evaluate safety and efficacy of dermatological products. Rise in number of approval of dermatological products acts as a key driving force of the global market. For instance, in December 2021, Amgen, a biopharmaceutical company, announced the Food and Drug Administration (FDA) approval of Otezla (apremilast), which is recommended for the treatment of patients diagnosed with plaque psoriasis.
Furthermore, rise in funds by governments of various countries and private organizations to develop pharmaceutical manufacturing units are expected to boost the market growth. For instance, in March 2020, the Department of Pharmaceutical, in India, announced the investment scheme of around $1,300 million to strengthen the domestic active pharmaceutical ingredient units and boost the manufacturing of pharmaceutical products. In addition, increase in R&D activities in pharmaceutical industry is anticipated to provide lucrative opportunities for the market expansion.

However, availability of alternative treatment options for acne and other skin diseases hinders the market growth. On the contrary, increase in awareness among population about various treatments available for skin diseases augments the growth of the dermatologicals market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the dermatologicals market.
The global dermatologicals market is segmented into disease, type, route of administration, and region. By disease, the market is categorized into acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and others. Depending on type, it is fragmented into prescription-based drugs and over-the-counter drugs. On the basis route of administration, it is segregated topical administration, oral administration, and parenteral administration. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermatologicals market are AbbVie Inc. (Allergan PLC)., Amgen Inc., Galderma, GlaxoSmithKline Plc., Johnson & Johnson Services Inc, Leo Pharma A/S, Novartis AG, Organon & Co (Merck), Pfizer Inc., and Sun Pharmaceutical Industries Limited.

KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global dermatologicals market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global dermatologicals market.

KEY MARKET SEGMENTS
By Disease
Acne
Dermatitis
Psoriasis
Skin Cancer
Rosacea
Alopecia
Others

By Type
Prescription-based drugs
Over-the-Counter drugs

By Route of Administration
Topical administration
Oral administration
Parenteral administration

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY MARKET PLAYERS
AbbVie Inc. (Allergan PLC).
Amgen Inc.
Galderma
GlaxoSmithKline Plc.
Johnson & Johnson Services Inc
Leo Pharma A/S
Novartis AG
Organon & Co (Merck)
Pfizer Inc.
Sun Pharmaceutical Industries Limited.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Acne Drugs Industry

  • $ 5600
  • October 2022
  • 93 pages

Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-pee ...

  • World
  • China
  • Acne Treatment
  • Pharmaceutical
  • Industry analysis

Global Face Cream Industry $ 5600 October 2022


ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on